Iraq or Afghanistan veterans had significantly higher rates of respiratory diseases in 10 years compared to non-veterans.

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal ...

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...

“Virginia’s humidity changes fast,” said Bane. “One day it’s damp and warm, the next it’s crisp and dry. That constant ...

People with extreme, life-threatening allergic reactions might do as well to use a nasal spray as to jab themselves in a ...

QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in Cash Represents a 139.7% premium to most recent Nasdaq closing price Transaction expected to close by the end of 2025 ...

Ever wondered why the color of your snot is different when you’re sick? You’re probably not the first person to ask this question. There are actually many ...

Tired of Botox and fillers that don’t deliver? Xeomin is emerging as a safer, cleaner neurotoxin that’s redefining non-surgical nose contouring.

Mucoceles are benign sinus tumors that are caused by an obstruction in the sinus ostium. We report 3cases managed at the University Hospital of Kamenge, where treatment was surgical via an endoscopic ...

Doctors took a look inside his nose and saw signs of blood. When they broke out the nasal endoscope, they saw the source of ...

Smith & Nephew Snats (($SNN)) announced an update on their ongoing clinical study. Smith & Nephew is currently conducting a post-market clinical ...

THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the ...